Table 2.
Hospital events.
| Unadjusted |
Propensity matched |
|||||
|---|---|---|---|---|---|---|
| Medical | CDL | p-Value | Medical | CDL | p-Value | |
| 240 | 99 | 99 | 99 | |||
| Index hospitalization events | ||||||
| Length of stay (days) | 6.0 (0.0–45.0) | 4.0 (1.0–16.0) | <0.001 | 6.0 (0.0–45.0) | 4.0 (1.0–16.0) | <0.001 |
| Patients with transfusion after PE | 22 (9.17%) | 2 (2.02%) | 0.02 | 14 (14.14%) | 2 (2.02%) | 0.018 |
| Patients with hemorrhages after PE | 5 (2%) | 3 (3%) | 0.39 | 5 (5%) | 3 (3.1%) | 0.21 |
| Types of hemorrhages | ||||||
| GI | 2 (0.83%) | 1 (1%) | 0.71 | 0 (0.0%) | 1 (1%) | 0.57 |
| Intracranial | 1 (0.41%) | 1 (1%) | 0.60 | 1 (1%) | 1 (1%) | 1 |
| Other | 2 (0.83%) | 2 (2%) | 0.77 | 1(1%) | 2 (2%) | 0.5 |
There was a decreased length of stay in patients treated with CDL compared to standard medical therapy. There was no significant increase in rates of transfusions or hemorrhages during the index admission for those treated with CDL. GI: gastrointestinal; PE: pulmonary embolism.